NovaDel Pharma Announces The Sale Of Its Nitromist® New Drug Application, License And Intellectual Property To Mist Pharmaceuticals, LLC.

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The transaction also includes the NovaDel patents and trademarks covered by NovaDel’s license agreement with Akrimax Pharmaceuticals, LLC for US rights to NitroMist® as well as the license agreement itself. The consideration for the sale was the assumption of the FDA fees, interest and penalties relating to NitroMist® owed by NovaDel up to the closing of the transaction. These fees, interest and penalties approximate $2,400,000.

Help employers find you! Check out all the jobs and post your resume.

Back to news